Josep Maria Ribera, MD, PhD, discusses the current standard treatment protocols for Philadelphia chromosome-positive acute lymphoblastic leukemia and the rationale behind them.

An international team of scientists has uncovered new insights into how the previously understudied duplicate X chromosome in ...

UCSF scientists have discovered a stem cell in the young brain that's capable of forming the cells found in tumors. The ...

While the story of Adam and Eve might seem far-fetched, there is now a growing body of evidence which suggests that at least ...

A genetic test typically involves submitting a saliva sample to a laboratory. Scientists then extract DNA from the saliva and ...

EBBH-2024 is under clinical development by Essen Biotech and currently in Phase II for Diffuse Large B-Cell Lymphoma.

EBBH-2024 is under clinical development by Essen Biotech and currently in Phase II for Refractory Chronic Lymphocytic Leukemia (CLL).

This is a useful study that adds new data to how different DAG pools influence cellular signaling, and dissects how the enzyme Dip2 modulates the minor lipid signaling DAG pool, which is distinct from ...

K.L.Duckworth, S.I.Rowe, A.Boggs, S.J.Dew Sounwave, J.M.Antonoff, Roselilah, M-Tech, Scott Bridgeway, K.Washington Loading ...

Pratteln, Switzerland, January 6, 2025 - Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of AGAMREE® ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

MOE Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen ...